MedTrace Logo

Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda

NCT01916759 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2014-04-23

No results posted yet for this study

Summary

To use a systems biological approach to study the molecular signatures of innate and adaptive responses to vaccination in a HIV infected versus uninfected adult population in Kampala, Uganda.

Conditions

Interventions

DRUG

Seasonal trivalent inactivated influenza vaccine (Vaxigrip®)

Administer seasonal trivalent inactivated influenza vaccine (Vaxigrip®) and collect blood specimens at 0, 1, 3, 7, 14, 28 and 100 days following vaccination.

Sponsors & Collaborators

  • Makerere University

    collaborator OTHER

  • Emory University

    lead OTHER

Principal Investigators

  • Saad B Omer, MBBS,MPH,PhD · Emory Unversity

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2013-12-31
Completion
2014-03-31

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01916759 on ClinicalTrials.gov